Cargando…
Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization
The Centers for Disease Control and Prevention (CDC) recommend that SARS-coronavirus (SARS-CoV) testing be considered in epidemiologically high-risk patients hospitalized with community-acquired pneumonia (CAP) if no alternative diagnosis is identified after 72 h. The aim of this study was to identi...
Autores principales: | Lee, N., Rainer, T. H., Ip, M., Zee, B., Ng, M. H., Antonio, G. E., Chan, E., Lui, G., Cockram, C. S., Sung, J. J., Hui, D. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088362/ https://www.ncbi.nlm.nih.gov/pubmed/17077967 http://dx.doi.org/10.1007/s10096-006-0222-z |
Ejemplares similares
-
PNEUMONIA | Community Acquired Pneumonia, Bacterial and Other Common Pathogens
por: Niederman, M.S.
Publicado: (2006) -
Can routine laboratory tests discriminate SARS‐CoV‐2‐infected pneumonia from other causes of community‐acquired pneumonia?
por: Pan, Yunbao, et al.
Publicado: (2020) -
Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
por: Mandell, Lionel A, et al.
Publicado: (2022) -
Laboratory test trends within 72 hours of hospital admission associated with death among COVID-19 patients
por: Zambrano, Sarah, et al.
Publicado: (2022) -
Variability in Pediatric Infectious Disease Consultants' Recommendations for Management of Community-Acquired Pneumonia
por: Hersh, Adam L., et al.
Publicado: (2011)